Macro
Thorny questions
1. Patents
The annual ‘Special 301’ report by the U.S. International Trade Commission (USTR) lists countries it claims are insufficiently committed to protecting intellectual property rights. There are three lists.
2. Subsidies
The U.S. and other developed nations blame India for stalling the Trade Facilitation Agreement (TFA). India opposes the TFA since it limits farm subsidies to 10% of the value of farm production at 1986-88 prices, and may hamper implementation of its Food Security Act.
3. Drug Quality
In the past two years, the U.S. Food and Drug Administration’s (USFDA) scrutiny of Indian drug factories has increased. Imports from some factories of companies such as Ranbaxy and Wockhardt have been banned. Indian pharma companies say the USFDA is unilateral and unreasonable.
4. Generics
Citing anti-cancer drugs Nexavar and Glivec as examples, U.S. pharma companies have been demanding action against India for not protecting patents. India allowed their generic versions to be made, arguing that it was a valid step necessary to make cancer treatment affordable.
5. Solar Energy
The Jawaharlal Nehru National Solar Mission requires project developers to source 50% of their equipment from domestic manufacturers. The U.S. claims this violates the General Agreement on Trade and Tariffs. The WTO Disputes Settlement Body is examining the issue.
Also Read
-
Was hardest to figure out business model: 40u40 2024 Sanjeev Barnwal of Meesho
-
Demand for e-2-wheelers up, tractors, earth moving equipment to pick up: TCI
-
25% IAS officers corrupt, incompetent, or inefficient; middle 50% complacent: D Subbarao
-
Zee posts ₹13 cr profit in Q4; board approves organisation restructuring
-
Twitter officially transitions to X.com : Elon Musk